OmniComm claimed that TrialOne provides all necessary web-based tools used to recruit study volunteers, schedule screening appointments, collect screening data, directly capture real-time data, track sample transfers and address the unique requirements of early phase studies.
Within each study, real-time electronic data is captured and validated directly at the subject’s bedside or at a subject queuing station. Enhanced workflow technology automates sample processing throughout the lab.
Additionally, TrialOne supports a myriad of directly attached biomedical monitoring devices such as the GE Healthcare Dinamap family of vital signs monitors and various ECG devices.
TrialOne enables Phase I Clinics to share data directly with other stakeholders via the internet and provides a flexible ad-hoc reporting tool to help export and report data in various formats including Adobe PDF, Microsoft Excel and Word. Further extensibility of the TrialOne suite via integration to our flagship EDC product, TrialMaster, using OmniConnect, our enhanced web services API, and an integrated pharmacy module is planned for release later this year.
Randy Smith, CTO of OmniComm, said: TrialOne is the only available product that handles all aspects of the Phase I process from subject recruitment and clinical workflow management to laboratory sample management.
Other EDC solutions used in later stage trials do not include a proactive data collection system, which is imperative for the very time sensitive data collection processes inherent to early stage clinical studies.